Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum
Mannheim, Germany
Treatment & access
- Treatments offeredLSD (MM120 — clinical trial)
- Access routeTrial
- Cost & coverage (registry status)Free within clinical trial
- Websitehttps://www.zi-mannheim.de
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicCentral Institute of Mental Health — Clinical trials
- Another programme at this clinicZentralinstitut für Seelische Gesundheit (ZI) Mannheim — PAT
About this provider
The Panorama study, a Phase 3 clinical trial of MM120 (lysergide, a pharmaceutical form of LSD) in generalized anxiety disorder, lists Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum in Mannheim, Germany, among its sites. The trial is registered on ClinicalTrials.gov under NCT06809595, the registry source cited by this record. As of 2026-08-07 the registry status is ACTIVE_NOT_RECRUITING: recruitment has closed, so this site is not accepting new participants. For enrolled participants, treatment within the trial is free of charge. The record was last verified on 2026-08-07.
Verification
- License / registryCTIS (EU Clinical Trials Information System)
- Official registryhttps://euclinicaltrials.eu/ctis-public/view/2024-513572-17-00
- Official registryhttps://clinicaltrials.gov/study/NCT06809595
- Provider websitehttps://www.zi-mannheim.de
- Last verified
Check your fit & enquire
Clinical trials access in Germany follows published criteria. A short pre-screening comes first — then your compiled summary goes to Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum only with your explicit consent, and you can download it for yourself either way.
Check my fit & enquire